Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
BMY
GSK
Add up to 3 more stocks
BMY
Bristol-Myers Squibb Company
-1.90%
$63.61-1.23Delayed quote: Aug 11, 2026, 4:00 PM EDT
Market Cap
$129.94B
52W Range
$42.52 - $68.10
GSK
GSK plc
-2.42%
$50.90-1.26Delayed quote: Aug 11, 2026, 4:00 PM EDT
Market Cap
$101.98B
52W Range
$37.80 - $61.70
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | 14.28 | 16.49 |
| Forward P/E | 9.62 | 14.58 |
| P/B Ratio | 5.95 | 4.56 |
| P/S Ratio | 2.70 | 2.39 |
| P/FCF Ratio | 11.61 | 11.36 |
| EV/EBITDA | 9.87 | 8.46 |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 70.2% | 72.7% |
| Operating Margin | 28.3% | 20.7% |
| Net Margin | 18.9% | 14.5% |
| ROE | 41.6% | 27.7% |
| ROA | 10.6% | 7.9% |
| ROIC | 15.0% | 16.6% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 1.53 | 0.82 |
| Quick Ratio | 1.38 | 0.52 |
| Debt/Equity | 1.93 | 1.03 |
| Interest Coverage | 7.26 | 12.14 |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | 3.9% | 3.4% |
| Payout Ratio | 72.5% | 47.3% |
| Yrs of Dividend Growth | 16 | 2 |
N/A includes metrics that are structurally not meaningful for a company's sector (e.g. EV multiples, free-cash-flow ratios, and working-capital ratios for banks and insurers). Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.